Prestige Consumer Healthcare (PBH) Shares Outstanding (2010 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Shares Outstanding (Entity) of $56.2 million for Q4 2025, little changed year-over-year from $55.9 million in Q4 2024, and little changed quarter-over-quarter from $56.2 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Shares Outstanding (2010 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $56.2 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) changed 0.46% year-over-year to $56.2 million; the TTM figure through Dec 2025 stood at $56.2 million (changed 0.46% YoY), while the FY2025 annual figure was $56.0 million, up 0.92% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $56.2 million, roughly flat from $56.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $56.2 million in Q4 2025, with the low at $54.0 million in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $55.3 million (2023), against an average of $55.2 million.
- The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) climbed 0.36% in 2021, then grew 1.17% in 2024.
- Prestige Consumer Healthcare's Shares Outstanding (Entity) stood at $54.4 million in 2021, then increased by 0.92% to $54.9 million in 2022, then advanced by 0.87% to $55.3 million in 2023, then grew by 1.1% to $55.9 million in 2024, then climbed by 0.46% to $56.2 million in 2025.
- Business Quant data shows PBH's Shares Outstanding (Entity) at $56.2 million in Q4 2025, $56.2 million in Q3 2025, and $56.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.11 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.27 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.99 Bn | 30.31 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.26 Bn | 19.60 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | 47.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.88 Mn |
| Dec 31, 2025 | 47.88 Mn |
| Sep 30, 2025 | 49.03 Mn |
| Jun 30, 2025 | 49.48 Mn |
| Mar 31, 2025 | 49.70 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 49.65 Mn |
| Jun 30, 2024 | 49.89 Mn |
| Mar 31, 2024 | 49.76 Mn |
| Dec 31, 2023 | 49.74 Mn |
| Sep 30, 2023 | 49.69 Mn |
| Jun 30, 2023 | 49.77 Mn |
| Mar 31, 2023 | 49.89 Mn |
| Dec 31, 2022 | 49.69 Mn |
| Sep 30, 2022 | 49.80 Mn |
| Jun 30, 2022 | 50.26 Mn |
| Mar 31, 2022 | 50.26 Mn |
| Dec 31, 2021 | 50.30 Mn |
| Sep 30, 2021 | 50.23 Mn |
| Jun 30, 2021 | 50.14 Mn |